Shopping Cart
Remove All
Your shopping cart is currently empty
FR104 is a humanized monoclonal antibody targeting CD28, inhibiting effector T cells, reducing T and B cell responses to rhMOG.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $197 | - | In Stock | |
| 5 mg | $596 | - | In Stock | |
| 10 mg | $959 | - | In Stock | |
| 25 mg | $1,420 | - | In Stock | |
| 50 mg | $1,920 | - | In Stock |
| Description | FR104 is a humanized monoclonal antibody targeting CD28, inhibiting effector T cells, reducing T and B cell responses to rhMOG. |
| Targets&IC50 | T lymphocyte:0.10 μg/mL |
| In vitro | FR104 inhibited T lymphocyte proliferation in a dose-dependent manner in mixed lymphocyte response assay with IC50 = 0.10 μg/mL. |
| In vivo | In juvenile baboons, FR104 is given intravenously at 5 mg/kg and the half-life of elimination is 8.4 days. |
| Synonyms | VEL-101, FR104 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CD28 |
| Molecular Weight | 126.08 kDa |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.